glp 1 drugs for rheumatoid arthritis semaglutide GLP-1 Psoriatic Arthritis: Can They Help? Could this treatment END Rheumatoid
Description
This peptide hormone is well known for its mediative effect in regulating cellular glucose transport in the periphery and has been demonstrated to cross the BBB through insulin transporters [128] to act on insulin receptors which are widespread throughout the brain, localized on neurons, astrocytes, and microglia [129,130,131]

Int J Ophthalmol

Topiramate is an antiepileptic drug, and this class carries an FDA warning about increased risk of suicidal thoughts and behavior

Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans

However, this early lead appears to be fading

In Phase 3 studies: Participants without diabetes taking orforglipron lost approximately 9% to 10% of body weight over roughly 36 to 40 weeks Participants with type 2 diabetes generally lost around 7% to 8% By comparison, Wegovy's landmark STEP trials reported approximately 14.9% average weight loss over 68 weeks